mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.04 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.05 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.05 |